Navigation Links
Biobetters in Key Markets - Opportunities for Biotechnology Companies to Sustain Innovation with Low Risk and High Value Offerings
Date:11/15/2012

Approval Pathways 5211.1 Biobetter Therapies 5211.2 Biosimilar Therapies 5212 India Regulatory Environment and Approval Pathways 5312.1 Biobetter Therapies 5312.2 Biosimilar Therapies 5313 Biobetter Companies 5413.1 Key Players 5413.1.1 Amgen 5413.1.2 SWOT Analysis 5513.1.3 Merck 5613.1.4 SWOT Analysis 5613.1.5 Roche 5713.1.6 SWOT Analysis 5813.1.7 Novo Nordisk 5913.1.8 SWOT Analysis 5913.1.9 Sanofi-Aventis 6013.1.10 SWOT Analysis 6114 Strategic Consolidations 6214.1 Deals Analysis 6214.1.1 Mergers and Acquisitions 6214.1.2 Licensing Agreements 6915 Biobetters Therapeutics Market to 2018 - Appendix 7615.1 Abbreviations 7615.2 Sources 7815.3 Research Methodology 7815.3.1 Coverage 7915.3.2 Secondary Research 7915.3.3 Primary Research 7915.3.4 Forecasts 8015.3.5 Expert Panel Validation 8215.4 Contact Us 8215.5 Disclaimer 82

List of Tables

1.1 List of TablesTable 1: Biobetters in Key Markets, Human Growth Hormone Therapeutics Pipeline, Development-stage Molecules, 2012 33Table 2: Biobetters in Key Markets, Erythropoietin Pipeline, Development-stage Molecules, 2012 34Table 3: Biobetters in Key Markets, Granulocyte-colony Stimulating Factor Pipeline, Development-stage Molecules, 2012 35Table 4: Biobetters in Key Markets, Interferon-? and ? Pipeline, Development-stage Molecules, 2012 37Table 5: Biobetters in Key Markets, Insulin Pipeline, Development-stage Molecules, 2012 39Table 6: Biobetters in Key Markets, Monoclonal Antibodies Pipeline, Development-stage Molecules, 2012 40Table 7: Biobetters in Key Markets, Monoclonal Antibodies Pipeline, Development-stage Molecules, 2012 (Contd.) 41

List of Figures

1.2 List of FiguresFigure 1: Biobetters in Key Markets, Erythropoietin, Global, Revenue Sales ($m), 2000-2011 13Figure 2: Biobetters in Key Markets, Granulocyte-colony Stimulating Factor, Global, Revenue Sales ($m), 2000-2011 14Figure 3: Biobetters in Key Markets, Interferon-alpha, Global, Revenue Sales ($m), 2000-2011 16Figure 4: Biobetters in
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. AspenBio to Present at 2012 Lazard Capital Markets Healthcare Conference
2. Palatin Technologies, Inc. To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
3. Regulus to Present at the Lazard Capital Markets Healthcare Conference
4. PDL BioPharma to Present at the Lazard Capital Markets 9th Annual Healthcare Conference
5. Tengion to Present at the Lazard Capital Markets 9th Annual Healthcare Conference
6. Sangamo BioSciences Announces Presentation At The Lazard Capital Markets Healthcare Conference
7. MiMedx Group to Present at the BIOX; Noble Financial Capital Markets Life Sciences Exposition
8. Kinase Inhibitors: Global Markets -- Focus on the U.S.
9. MarketsandMarkets: Global Refurbished Medical Equipments Market worth $8.45 Billion by 2017
10. MarketsandMarkets: Global Spine Surgery Devices Market Worth $14.8 Billion by 2017
11. MarketsandMarkets: World Sensors Market in Healthcare Applications is expected to reach $13.11 billion by 2017
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... Capillus, LLC announces plans to expand ... Europe and Asia. The Miami-based medical device manufacturer ... Business Development Director of Svenson Group Europe, as ... professional achievements include increasing the number of Svenson ... the Portuguese marketplace with centers in Lisbon and ...
(Date:4/16/2015)... 16, 2015 OncoTAb, Inc., ... (UNC Charlotte) spin-out company, announced today the appointment ... M.D., as Chief Operating Officer (COO). Cooper brings ... in developing clinical diagnostic and biotechnology platforms in ... , Cooper’s extensive career transcends the field of ...
(Date:4/16/2015)... ON , April 16, 2015 /CNW/ - Bioenterprise Corporation ... its newest office in Charlottetown , ... the Prince Edward Island ADAPT Council for the commercialization ... looking forward to working with PEI ADAPT.  They have ... for more than a decade," explains Dave Smardon ...
(Date:4/16/2015)... 16, 2015 Avelas Biosciences, an in ... surgeries, announced today that it has initiated a Phase ... in women with primary, non-recurrent breast cancer undergoing surgery. ... the addition of Steven Chen , M.D., as ... label, dose escalation study will enroll up to 39 ...
Breaking Biology Technology:Capillus, LLC Extends Laser Hair Therapy Products to Europe and Asia 2OncoTAb Names Dr. David L. Cooper as COO 2Bioenterprise Corporation Expands into the Maritimes 2Avelas Biosciences Initiates Phase 1b Trial of AVB-620 in Breast Cancer Patients 2Avelas Biosciences Initiates Phase 1b Trial of AVB-620 in Breast Cancer Patients 3
... Wis. - Supply-chain technology firm RedPrairie has launched ... ship directly to consumers or use drop shipping. ... order sourcing called Dlx SourceRight, which the company ... process and production management systems. , ,DLx SourceRight ...
... growth, Wisconsin is running low on investment fuel. A ... 32nd out of 50 in availability of the risk capital ... successes. That may soon change thanks to the recent ... ,Act 255 encourages angel investors and venture capitalists to invest ...
... do not specialize in software, but incorporate software-based components ... often than not, overlook the importance of protecting that ... or the most prevalent feature of the product, but ... should be protected. , ,For example, many vehicles, ...
Cached Biology Technology:An analysis of Wisconsins new venture capital and early stage finance programs 2An analysis of Wisconsins new venture capital and early stage finance programs 3Beyond the screws and gears: Protecting your products by protecting your software 2
(Date:4/14/2015)... April 14, 2015 NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market, announces ... the 2015 New York Design Awards under the category  ... York City Design Awards are part of a global ... 2,500 ratings from the marketplace, industry and judging panel. ...
(Date:4/13/2015)... , April 13, 2015  higi, a leading cloud-based ... to more fully engage with their communities around health ... privacy protected and secure API.  ... the most accessible, affordable, and convenient vehicle to receive ... The API will allow higi,s ...
(Date:4/9/2015)... Calif. , April 9, 2015 Synaptics ... interface solutions, announced today that it will report financial ... Thursday, April 23, 2015, after the close of market. ... analysts and investors at 2:00 p.m. PT (5:00 p.m. ... To participate on the live call, analysts ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3Synaptics to Report Third Quarter Results on April 23 2
... (Edmonton) A University of Alberta polar bear researcher along ... planning for rapid Arctic ecosystem change to deal with ... of A professor Andrew Derocher co-authored a policy perspective ... with polar bear populations to accept that just one ...
... of American Societies for Experimental Biology (FASEB) announces ... Conference (SRC): TGF-β Superfamily: Signaling in Development and ... Development and Disease" is an important and unique ... family members in developmental and homeostatic processes is ...
... This release is available in French . ... dependent on the brain,s ability to be plastic that is ... new study from the Montreal Neurological Institute The Neuro, McGill ... the nervous system known as netrin, plays a key role in ...
Cached Biology News:Polar bear researchers urge governments to act now and save the species 2Finding the way to memory 2Finding the way to memory 3
This kit only detects beta-galactosidase activity at pH 6 in cultured cells andtissue sections. Beta-galactosidase activity at pH 6 ispresent only in senescent cells, and is not found inpresenescent...
For the quantitative determination of cyclic AMP (cAMP) concentrations in cell culture supernates, serum, plasma, saliva, urine and cell lysates....
FRACTALKINE [Human] (Recombinant)...
... the end of determination; triple-point calibration verification; refrigerator eliminates need for pumps and bath liquid; rapid cooldown; bench-saver ... * Range: 0-3000 mOsm/kg ... ... ...
Biology Products: